Novartis’ Sandoz Settles U.S. Drug Price-Fixing Charges

(Bloomberg) -- Novartis AG’s Sandoz unit agreed to pay $195 million to settle U.S. criminal charges that it conspired with other pharmaceutical companies to fix prices of generic drugs, the most si...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.